Evidence map›Paper›PMID 17904917›Full record

Trial reportContemporary clinical trials2008

Treating persistent depressive symptoms in post-ACS patients: the project COPES phase-I randomized controlled trial.

Matthew M Burg, Francois Lespérance, Nina Rieckmann, Lynn Clemow, Christine Skotzko, Karina W Davidson

Registry-linked trialAbstract readClinical Trial, Phase IMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03878160 (Mindfulness-Based Cognitive Therapy Delivered Via Group Videoconferencing for Acute Coronary Syndrome Patients With Elevated Depression Symptoms), which is not on this map. Cited by 16 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03878160 nacompletednot on this mapstarted 2018, after this paper: background citation

Mindfulness-Based Cognitive Therapy Delivered Via Group Videoconferencing for Acute Coronary Syndrome Patients With Elevated Depression Symptoms

TypeinterventionalSponsorMassachusetts General HospitalRan2018 to 2020Enrolled27ConditionsAcute Coronary Syndrome, Depression, Myocardial Infarction, Unstable AnginaArmsIndividual Interview
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Psychological interventions for coronary heart disease.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Pooled it
  4. Interventions for enhancing medication adherence.The Cochrane database of systematic reviews · 2014
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthew M BurgBehavioral Cardiovascular Health & Hypertension Program, Columbia University School of Medicine, New York City, NY 10032, United States. mb2358@columbia.edu
Francois Lespérance
Nina Rieckmann
Lynn Clemow
Christine Skotzko
Karina W Davidson

Funding

Controlled Randomized Anger Reduction in HypertensivesK23HL004458 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI DAVIDSON, KARINA W. · 2001 to 2005
$644k
TRANSLATIONAL BEHAVIORAL SCIENCE RESEARCH CONSORTIA-N01HC25197N01HC025197 · HC · MOUNT SINAI SCHOOL OF MEDICINE · 2002 to 2005
–
NHLBI NIH HHS HC-25197NHLBI NIH HHS HL-04458NHLBI NIH HHS K23 HL004458NHLBI NIH HHS N01 HC025197
6 · The paper itself

Abstract

Depression and sub-syndromal depressive symptoms are important predictors of morbidity and mortality after acute coronary syndrome (ACS). Prior trials of depression treatment in post-ACS patients have demonstrated no improvement for event-free survival, and only modest improvement in depression symptoms. These trials have raised a number of important issues regarding timing of depression intervention, acceptability of depression treatment to ACS patients, and safety for subsets of the treated population. This article describes Project COPES (Coronary Psychosocial Evaluation Studies), a multi-center Phase-I randomized clinical trial. Project COPES uses a patient preference depression treatment that has previously been found acceptable to medical patients, and a 3-month pre-randomization observation period to insure depression status. The study sample will include 200 post-ACS patients. The primary outcome is patient satisfaction with depression care. Secondary, exploratory aims include the acceptability of depression treatment, reduction in depressive symptoms, and the effects of treatment on two key pathways--medication adherence and inflammation--hypothesized to link depression to post-ACS prognosis. These analyses will provide important data to inform subsequent clinical trials with this population.

Indexed as

Patient Acceptance of Health CareAcute Coronary SyndromeDepressive DisorderDisease-Free SurvivalHumansInformed ConsentNeutrophil InfiltrationTreatment Outcome

Identifiers

PMID17904917
PMCPMC2315791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.